Brief: Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
22/08/2024 13:09
Aug 22 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA ANNOUNCES INITIATION OF REFRΑME-L1 PHASE 2
TRIAL
WITH LUVELTA FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER
* SUTRO BIOPHARMA INC -INITIAL DATA FROM THIS STUDY IS
EXPECTED IN
FIRST HALF OF 2025
Source text for Eikon: ID:nGNX3jW8zj
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates